Ocata Therapeutics, first ever hesc trials have "provided reassurance of safety", it's "unexpectedly encouraging". Three year track record, 38 patients, growing culmination of hard work by the Lanza/Team and trial associates.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.